George A. Joulwan, Director at Emergent BioSolutions Inc. (EBS), sold 5,000 shares at $52.89 ($264K) on 2018-06-11, disclosed to the SEC on 2018-06-12.
Open-market sale of $264k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EBS | SELL | 2018-11-08 | $556K | — | Filing → |
| EBS | SELL | 2017-11-09 | $1.2M | — | Filing → |
| EBS | SELL | 2016-06-07 | $207K | — | Filing → |